We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Globus Medical Inc (GMED) USD0.001 A

Sell:$65.44 Buy:$65.48 Change: $0.52 (0.79%)
Market closed |  Prices as at close on 24 May 2022 | Switch to live prices |
Change: $0.52 (0.79%)
Market closed |  Prices as at close on 24 May 2022 | Switch to live prices |
Change: $0.52 (0.79%)
Market closed |  Prices as at close on 24 May 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Globus Medical, Inc. is a medical device company. It is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. It groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. It offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screw and rod systems.

Contact details

2560 General Armistead Ave
United States
+1 (610) 9301800

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$6.72 billion
Shares in issue:
101.73 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • David Paul
    Executive Chairman of the Board
  • Daniel Scavilla
    President, Chief Executive Officer, Director
  • Keith Pfeil
    Chief Financial Officer, Senior Vice President
  • Kelly Huller
    Senior Vice President, General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.